Critical to the wellbeing of pregnant women and their infants is universal screening for drug and alcohol use. This is an essential first step in identifying women with harmful substance use and connecting them with appropriate services. Screening, Brief Intervention and Referral to Treatment or SBIRT has been shown to be a quick and effective… Read More »
In 2019, the Food and Drug Administration (FDA) approved brexanolone, marketed by Sage Therapeutics as Zulresso, as a treatment for postpartum depression (PPD). As a neurosteroid, brexanolone represents a novel approach to the treatment of postpartum mood disorders. One of the most exciting things about brexanolone is the rapidity of the response, with the initial… Read More »
According to a report published by the CDC in Morbidity and Mortality Weekly Report (MMWR), the use of stimulant medications for the treatment of attention-deficit/hyperactivity disorder (ADHD) by reproductive-age women is on the rise. In 2003, 0.9% of women between the ages of 15 and 44 filled a prescription for an ADHD medication, compared to… Read More »
Sharing the books I read in April and if I’d recommend them! Still going strong with my goal of at least three books per month. Hi friends! Happy Monday! How was the weekend? I hope it was fun and relaxing! Ours was a great one. P had a soccer game, the Pilot and I had… Read More »